Clinical Trials Browser

Phase 1 × VB6-845 fusion protein × Clear all

NCT00481936 2023-03-23

Study of the Safety of VB6-845 in Patients With Advanced Solid Tumours of Epithelial Origin

Phase 1 Terminated

Neoplasms, Neoplasms, Glandular and Epithelial